Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
Quick Stats
Jan 30, 202660.3
AI Score
BUY0.61
Volume Ratio
Feb 24, 2026
Next Earnings
13
+ve Days (30d)
16
-ve Days (30d)
DAWN Stock Summary
Last updated Jan 30, 2026
DAWN is currently trading at $11.16, positioned above its 200-day moving average of $7.72, indicating a long-term uptrend. The stock has a 52-week range of $5.635 to $13.2.
Technical Analysis: The 50-day moving average stands at $9.61, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 54.887, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.102, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates DAWN at 60.3/100 with a BUY recommendation.
DAWN (Day One Biopharmaceuticals, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 54.887 |
| CMF (20) | -0.102 |
| ROC (10) | 6.286 |
| ADX (14) | 38.698 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.675 |
| AROONOSC (14) | 50.0 |
| WILLAMS %R (14) | -60.714 |
| MFI (14) | 57.541 |
DAWN Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
DAWN Price vs Max Options Open Interest
DAWN Max Change In Options Open Interest
DAWN Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DAWN Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DAWN Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
DAWN Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Day One Biopharmaceuticals, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
DAWN Moving Averages Analysis
Day One Biopharmaceuticals, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
Day One Biopharmaceuticals, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
DAWN (Day One Biopharmaceuticals, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 11.72 |
| 20 | 10.71 |
| 30 | 10.28 |
| 50 | 9.61 |
| 100 | 8.62 |
| 200 | 7.72 |
DAWN Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.2 billion |
| Earnings/Share ($) | -1.52 |
| Net Proft Margin (%) | -1.1353 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.9477 |
| EPS Estimate Next Year ($) | -0.5431 |
| WallStreet Target Price ($) | 23.5556 |
| Most Recent Quarter |